-
1
-
2
-
3
One step closer to solving the mystery of the anti‐inflammatory effects of glucagon‐like peptide‐1 receptor agonists
Published 2025-02-01Subjects: Get full text
Article -
4
-
5
Enhanced renoprotective effects of combined glucagon‐like peptide‐1 receptor agonists and sodium‐glucose cotransporter 2 inhibitors in type 2 diabetes mellitus: Real‐world evidence...
Published 2025-02-01Subjects: “…Glucagon‐like peptide‐1 receptor agonists…”
Get full text
Article -
6
Efficacy and safety of glucagon-like peptide-1 receptor agonists in the elderly versus non-elderly patients with type 2 diabetes mellitus: insights from a systematic review
Published 2024-06-01Subjects: “…glucagon-like peptide-1 receptor agonists (glp-1ras)…”
Get full text
Article -
7
-
8
Use of Glucagon-Like Peptide-1 Receptor Agonists Does Not Increase the Risk of Cancer in Patients with Type 2 Diabetes Mellitus
Published 2025-01-01Subjects: Get full text
Article -
9
Adverse effects of GLP – 1 Receptor Agonists
Published 2025-02-01Subjects: “…obesity, glucagon – like peptide – 1 receptor agonists…”
Get full text
Article